Anne Pereira

H. Anne Pereira, PhD

Chief Scientific Officer & Co-Founder

Dr. Pereira received her PhD in Pathology from the University of Melbourne in Australia and then served as a postdoctoral fellow/senior research associate at Emory University in Atlanta, before accepting a position at the University of Oklahoma.

While at Emory University as a senior research associate/postdoctoral fellow in the laboratory of Dr. John Spitznagel, she initiated the scientific investigations into the multifunctional aspects and identification of bioactive peptides based on the innate immune system molecule, CAP37.

She has the distinction of being named a Fellow by the American Association for the Advancement of Science (AAAS) and a fellow of the American Association of Colleges of Pharmacy (AACP) Academic Research Program. She is a renowned scientist in the areas of antibiotics and anti-inflammatory therapeutics, and has had a longstanding record of federal funding.

Dr. Pereira is the holder of 15 US patents and 4 foreign patents licensed to Biolytx. She was named a Fellow of the National Academy of Inventors in 2015 for her highly prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and the welfare of society. In 2016 she received the OK Bio Researcher Recognition award.